Fewer dead ends when designing molecular sensors
- What it is
- A machine-learning method that uses experimental libraries to choose promising target sites for RNA sensors.
- Who did it
- Jihoon Han and Seth L. Shipman at Gladstone Institutes and UCSF.
- What it could mean
- Could make early molecular-sensor research more efficient if the selection advantage generalizes.
See the check plan
Evidence & validation
From announcement to evidence
Discovery recorded. The source reports the evidence below; State of Proof has not independently reproduced the work.
Read the original work
High-throughput variant libraries and machine learning enable robust target-site selection for toehold-switch design in Detectrons ↗See the proposed checks
Review the held-out comparison, uncertainty and generalization limits; retain high-level, non-procedural coverage.
Independent examination not started
Peer review, simulation comparisons, laboratory evidence and independent replication are distinct. Inclusion here does not establish all of them; see the record’s source and current boundary.
How we distinguish research evidence →
Finding promising molecular-sensor targets
The highlighted interface represents candidate selection at a high level. These are invented molecular forms, not actual sequences, protein structures or an experimental design.
Read the source · Abstract · target-site ranking and held-out evaluation ↗- Source kind
- Experimentally tested research method
- Evidence reported
- Experimental training libraries; Prospective held-out transcript test
- AI role
- Machine learning ranks candidate target sites for RNA sensors.
- Human role
- Researchers generated training libraries and performed prospective laboratory tests.
- Source date
- ; added 2026-10-15
- What it claims
- The authors report improved RNA-sensor target-site selection using experimental libraries and a machine-learning ranking method, evaluated on a held-out transcript.
- Why this could matter
- Fewer dead ends when designing molecular sensors A ranking model could reduce trial and error when choosing sensor targets. The reported laboratory comparison does not establish clinical performance or a diagnostic product.
- If it holds up
- Researchers could test fewer unproductive sensor candidates before finding a working design.
- If it does not
- Additional transcripts would reveal where target-site rankings fail to generalize.
- Impact horizon
- Methods · Molecular sensors · Experimental prioritization
- Version
- bioRxiv v1; posted October 12, 2026
- Why we tracked it
- A new October 12 preprint with a prospective laboratory comparison; the DOI's October 9 component is not its posting date.
- Highest-risk dependency
- Preprint findings may not generalize beyond the tested transcripts; clinical sensitivity, specificity and patient outcomes were not established.
- Available artifacts
- Versioned bioRxiv manuscript and linked supplementary material; no laboratory reproduction by State of Proof.
- Current boundary
- Intake record only; examination not started. Unreviewed preprint intake; independent examination and replication have not started. Laboratory sensor selection is distinct from clinical validation.